Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta‐analysis

Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta‐analysis

Abstract Background and Aim Ulcerative colitis (UC) causes chronic inflammation in the digestive tract, leading to abdominal pain and diarrhea. Adalimumab, a monoclonal antibody, is used to treat moderate to severe cases. This review and meta‐analysis evaluated adalimumab's effectiveness for se...

Full description

Bibliographic Details
Main Authors: Saleh Azadbakht, Masomeh Seighali, Salehe Azadbakht, Morteza Azadbakht
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Health Science Reports
Subjects:
abdominal pain
adalimumab
diarrhea
digestive
monoclonal antibody
ulcerative colitis
Online Access:https://doi.org/10.1002/hsr2.2210

Internet

https://doi.org/10.1002/hsr2.2210

Similar Items